
A key opinion leader considers the physical and economic impact of hepatic encephalopathy on patients.
A key opinion leader considers the physical and economic impact of hepatic encephalopathy on patients.
An overview of the AASLD (American Association for the Study of Liver Diseases) 2014 Practice Guidelines regarding the diagnostic process for patients with hepatic encephalopathy at risk for recurrence.
An expert physician considers how to best adapt care for outpatients with recurrent hepatic encephalopathy.
A key opinion leader enumerates the unmet needs in the management of hepatic encephalopathy, and provides insight into promising clinical developments.
A discussion on the importance of increasing awareness of hepatic encephalopathy for primary care providers/physicians.
An expert physician considers the challenges that arise with ICD10 coding in delivering care for patients with hepatic encephalopathy and risk adjustment.
A key opinion leader provides advice for primary care physicians/providers treating patients with hepatic encephalopathy.
A key opinion leader considers the physical and economic impact of hepatic encephalopathy on patients.
An overview of the AASLD (American Association for the Study of Liver Diseases) 2014 Practice Guidelines regarding the treatment of patients with encephalopathy, with special consideration to the diagnosis of individuals in the outpatient setting, grading of severity, and treating at-risk populations.
A discussion on the transition of care issues for patients leaving the hospital with hepatic encephalopathy, to receiving appropriate follow-up management.
A key opinion leader enumerates the unmet needs in the management of hepatic encephalopathy, and provides insight into promising clinical developments.
A discussion on the importance of increasing awareness of hepatic encephalopathy for primary care physicians/providers seeing at-risk patients.
An expert physician considers the challenges that arise with ICD10 coding in delivering care for patients with hepatic encephalopathy and risk adjustment.